# FOLFOXIRI With or Without Intensification for Rectal Cancer

> **NCT03997435** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **CCTU** · enrollment: 72 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Control arm
- **DRUG:** Experimental arm

## Key facts

- **NCT ID:** NCT03997435
- **Lead sponsor:** CCTU
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03997435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03997435, "FOLFOXIRI With or Without Intensification for Rectal Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03997435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*